The half-life of [ For normal rabbits we obtained a half-life of 15.8 hours (method I) and 17.5 ± 1.0 hours (mean ± SEM, method II), respectively. The second method was used to estimate the kinetics of the hyaluronan elimination from normal, sham-operated, as well as from osteoarthritic rabbit knee joints (Colombo model of osteoarthritis). Four weeks after injury, during the developing phase of osteoarthritis, the half-life of hyaluronan rose significantly to 23.5 ± 2.1 hours and returned to normal levels (17.4 ± 2.7 hours) 12 weeks after the operation (osteoarthritis developed). At the stage of developed osteoarthritis, the clearance rates were considerably higher than in normal rabbits.
Introduction
Hyaluronic acid (hyaluronan) is a high molecular mass component of the synovial fluid that is responsible for its unique viscoelasticity as well as for other specific properties. Synovial fluid fulfills several physiological protective functions in the joint cavity such as shock absorption, traumatic energy dissipation and storage, radical scavenging and the protective coating of the articular cartilage surface and of the inner lining of the synovium, as well as controlling the "traffic" between the synovial vessels and the cartilage by an exclusion effect on migrating cells and larger molecules (1) . Recently, repeated intra-articular injections of hyaluronan have been widely used in the treatment (1 -4) of osteoarthritis.
Hyaluronan of the synovial fluid is synthesized by lining cells and leaves the joint cavity via the lymphatic system (5-7). The mean intrasynovial half-life of hyaluronan in rabbits has been found with high molecular mass [ (6) . After entering the circulation, it is quickly cleared from the blood by the sinusoidal endothelial cells of the liver (t-/ 2 = 2.5-4.5 min, (8, 9) ). Therefore, the concentration of hyaluronan in serum is several orders of magnitude lower (30-40 §/1, (7, 10)) ! ) This work is part of a project which was supported by grants (01ZU9102) from the Bundesminister für Forschung und Technologie, Germany than in synovial fluid (3 g/l). In osteoarthritis the synovial fluid in general is more abundant and less viscous, whereas the concentration of hyaluronan is decreased and its molecular mass is reduced (2) . The content of hyaluronan in the joint is elevated, because the volume of synovial fluid is enhanced in osteoarthritis (11) . These alterations severely impair the physiological functions of the synovial fluid. In osteoarthritic synovium from dogs an enhanced rate of hyaluronan synthesis has been described (12, 13) . It has not been reported whether the elimination rate of hyaluronan from the joint is changed under osteoarthritic conditions. Therefore, we have estimated the intrasynovial half-life of biochemically synthesized [ 3 H]hyaluronic acid using the osteoarthritis model of Colombo et al. (14) . Using an experimental model it is possible to measure the half-life of hyaluronan at different stages of the osteoarthritic process and to answer the question whether the determination of hyaluronan elimination rates of injured knee joints may be useful for the early diagnosis of osteoarthritis.
Materials and Methods

Animals
Nineteen chinchilla rabbits, weighing 2.7 to 3.2 kg, were randomly divided into four groups: non-operated control animals (n = 5), sham-operated animals (n = 3), osteoarthritis group "4 weeks after operation" (n = 5) and osteoarthritis group "12 weeks after operation" (n = 6). In the osteoarthritis groups the fibular collateral and sesamoid ligament of the left knee were dissected and 4-5 mm of the anterior lateral area of the exposed meniscus was removed (14) . In the sham-operated group the joint cavity was opened, the patella dislocated, as in the case of operation, and then reset. Finally the joint capsule and skin were sutured. Colombo et al. (14) only cut the skin in the sham-operated group.
For operation the animals were anaesthetized with 50 mg/kg ketamine (Ketanest®, Parke-Davis) and 5 mg/kg xylazin (Rompun vet®, Bayer).
Histology
After sacrifice both femur condyles were excised, fixed in 100 g/1 formalin in 0.05 mol/1 phosphate buffer (pH 7.2) containing 5 g/1 cetyl trimethylammonium bromide, decalcified with 50 g/1 nitric acid and sections stained with haematoxylin/eosin and according to Masson-Goldner's method (15), respectively. Synovium harvested together with both the joint capsule and patella was fixed in Kryofix® (Merck 5211) and embedded in paraffin after decalcification with 50 g/1 nitric acid.
Harvesting of synovial fluid by the dilution method (11, 16) The animals were anaesthetized with thiopental-Na (Trapanal®, Byk Gulden, Germany) and received a 2.0 ml intra-articular injection of 5 g/1 hydroxyethyl starch (average relative molecular mass 200 000, Fresenius AG, Bad Homburg) in saline. After passive motion of the joint for 5 min the mixture of hydroxyethyl starch solution and synovial fluid was aspirated. From the difference in the hydroxyethyl starch concentration between the injected hydroxyethyl starch (HES) solution and aspirated mixture, the volume of the synovial fluid and dilution factor of the aspirated mixture were calculated: The hydroxyethyl starch concentration of joint aspirates was determined as described for "depot glucose" in I.e. (16) . Briefly, 100 μΐ test solution and 20 μΐ 420 g/l KOH were heated in a small test tube (diameter 11 mm, length 100 mm) in boiling water for 5 min. After cooling, 50 μΐ 20 g/1 Na 2 SO 4 solution and 1 ml 96% alcohol (0.960 1/1, volume fraction 0.96) were added and the tubes kept at 6 °C over night. After centrifugation at 2200 g for 10 min, the precipitate was washed with 500 μΐ of 80% alcohol (0.8 1/1, volume fraction 0.8), dried and mixed with 2.5 ml 0.6 mol/1 HC1. The tubes were sealed and heated in boiling water for 5 hours. The acid hydrolysate (400 μΐ) was neutralized in a small test tube by adding 100 μΐ of a saturated KHCO 3 solution. The developing CO 2 was eliminated by vigorous shaking. The glucose concentration of the neutralized hydrolysate was determined using the Test Kit "Glucose-Test 180" (Fermognost, Feinchemie Sebnitz GmbH, Germany) according to the manufacturer's instructions. The intra-and inter-assay coefficients of variation of the hydroxyethyl starch determination were 1.2% and 2.0%, respectively. 
Measurement of hyaluronan concentration
The concentration of hyaluronan was determined using the thiobarbituric acid method (18) after enzymatic digestion of the samples with hyaluronidase from Streptomyces hyalurolyticus nov. sp. (Calbiochem, EC 4.2.99.1). This enzyme specifically cleaves hyaluronan to unsaturated oligosaccharides which were quantified by reaction with thiobarbituric acid (18) . Chondroitin sulphate, chondroitin, heparin, keratan sulphate, and chitin were not degraded by this hyaluronidase (19) .
Briefly, 50 μΐ joint aspirate (mixture of hydroxyethyl starch and synovial fluid) containing between 0.2 and 1.0 g/1 hyaluronan were incubated with 50 μΐ 0.04 mol/1 sodium acetate buffer (pH 5.2) and 50 μΐ hyaluronidase (10 5 turbidity-reducing units/1) in 0.4 mol/1 sodium acetate buffer (pH 5.2) at 60 °C for 3.5 h. For each aspirate an own blank was prepared (50 μΐ aspirate, 50 μΐ 0.04 mol/1 sodium acetate buffer pH 5.2, 50 μΐ 0.4 mol/1 sodium acetate buffer pH 5.2). The assay was performed as described byJourdian et al. (18) . The absorbance of the butanol layer was determined at 552 nm. Recovery of hyaluronan upon addition to aspirates was 98%. The intra-and inter-assay coefficients of the hyaluronan determination were 1.06% and 1.9%, respectively. Hyaluronan was dissolved in hydroxyethyl starch solution for establishing the standard curve. To evaluate the thiobarbituric acid method, the hyaluronan concentration of the joint aspirates was also quantified using the radiometric assay of Pharmacia AB (Uppsala, Sweden). The correlation between the methods was very high (correlation coefficient r = 0.98). knee joints. Synovial fluid from the first rabbit was harvested 12 hours after injection, from the second one after 24 hours and from the third one after 48 hours. Before mixing with the scintillator the joint fluids had to be digested by hyaluronidase. Without this preceding digestion, the hyaluronic acid slowly precipitates and no reproducible count rates will be obtained. The total activity of [ figure  4 . Half-life of hyaluronan, mean residence time and tmax were significantly higher in the osteoarthritis group "4 weeks after operation" (developing osteoarthritis) than in the group of non-operated animals (tab. 4) and achieved normal values 12 weeks after the operation (developed osteoarthritis). The differences between the group of non-operated control animals and the osteoarthritis group "12 weeks after operation" were not significant (tab. 4). Differences between the sham-operated group and the osteoarthritis group "4 100 r weeks after operation" were not significant due to the high variance and low animal number in the shamoperated group. It was remarkable that one animal of the sham-operated group, which also had elevated half-life, t m 'ax and mean residence time, did not use his sham-operated leg to walk. Histological examination revealed no osteoarthritic changes in the articular cartilage layer of this leg. 
Histological findings
The opening of the joint capsule in the sham-operated group caused a slight disorganization of chondrocytes in comparison to the contralateral non-operated knee joint.
At 4 weeks post-surgery, the cartilage layer was characterized by slight fibrillations, a heavy disorganization of chondrocytes, clones near the articular surface and some fissures. The cartilage layer was very rich in cells. Only one animal of this group showed a partial erosion of the cartilage layer. At 12 weeks after surgery the alterations were more pronounced. The cartilage layer displayed fibrillations, disorganization of cells and deep clefts, but only one animal showed areas where the bone was denuded.
At 6 weeks after surgery, the synovium showed a low hyperplasia and a slight cell infiltration. In addition, 12 bated with hyaluronidase from Streptomyces hyalurolyticus and analyzed again by size-exclusion chromatography on Sepharose. The void volume peak was completely eliminated and appeared at V t ( fig. 9 ). This indicates that a small part of test for statistical evaluation we found a significantly lower hyaluronan concentration in the osteoarthritis group "4 weeks after operation" in comparison to the osteoarthritis group "12 weeks after operation", whereas hyaluronan content of the osteoarthritis group "4 weeks after operation" was significantly higher than that of the group of non-operated animals.
Discussion
After intra-articular injection of small amounts of (ii) we used chinchilla rabbits whereas Brown et al. used English lop-eared rabbits. We suppose that the differences in hyaluronan half-life reflect breed-related variations.
Four weeks after surgery, during the phase of developing osteoarthritis, the half-life of hyaluronan rose significantly to 23.5 hours and returned to normal levels 12 weeks after operation (developed osteoarthritis). Similarly t max and mean residence time were enhanced 4 weeks after operation and dropped to normal levels 12 weeks after operation. Correspondingly, the fractional turnover rate of hyaluronan (k H A' 100) was lowered from 4.02% to 3.06% during the phase of developing osteoarthritis but was not significantly different from the non-operated control group in the phase of developed osteoarthritis.
We suppose that changes in the synovium might be responsible for the elevated half-life of hyaluronan because high molecular mass compounds, such as hyaluronan and proteoglycans, leave the joint through the intercellular space and the lymphatic endothelium (5, 6) . Therefore, alterations of the synovium such as thickening, inflammation, hyperplasia or accumulation of hyaluronan at the lining layer may influence the passage of hyaluronan into the lymphatic vessels and thus cause a change of half-life of hyaluronan. But we found only mild inflammatory signs and hyperplasia of the synov- Osteoarthritis group "12 weeks after operation" 2.27 ± 0.13 n = 3 2.01 ± 0.95 n = 3 ium, so that the reason for the half-life elevation in the phase of developing osteoarthritis remains unclear.
The enhanced values of half-life of hyaluronan in the phase of the developing osteoarthritis cannot be explained by the surgery because 2 out of 3 animals in the sham-operated group showed normal half-lives. However, as a response to the sham operation (4 weeks after operation), the volume of the synovial fluid in the shamoperated knee joints was higher than in the knee joints of the non-operated control animals (see tab. 3). In interpreting clearance studies, both half-life as well as intra-articular fluid volume, in which the injected [ 3 H]hyaluronan was distributed, must be taken into consideration (23, 24) , because the clearance rate of hyaluronan (volume of joint fluid cleared in unit time) depends not only on the rate constant k HA (or ti/ 2 ) but also on volume (clearance rate = k X distribution volume). If the volume of synovial fluid is enhanced, then the mechanism removing hyaluronan from the joint must have been enhanced. Whereas k H A of normal and osteoarthritic rabbit knee joints did not differ significantly at the stage of developed osteoarthritis (tab. 4), the clearance rates of the osteoarthritis group were considerably higher in comparison to the non-operated control group (tab. 3) due to the significantly higher synovial fluid volumes of the osteoarthritis group (tab. 4).
Heilmann
The clearance of low molecular mass components such as iodide (t/ 2 : 0.6 to 1.3 hours) is interpreted as a measure of synovial plasma flow, whereas the clearance of high molecular mass compounds such as albumin (t/ 2 : 8 to 17 hours), hyaluronan (t/ 2 : 11 to 31 hours) or proteoglycan (t./ 2 : 12 to 17 hours) is considered as representing the rate of lymphatic drainage from the joint (6, 25) . Brown et al. already suggested a common pathway for the elimination of hyaluronan and proteoglycan monomers from the joint cavity because of the striking similarity between their half-lives (6).
Clearance and half-life of different high molecular mass compounds were determined by several authors under conditions of low and high grade synovitis. Myers et al. provoked a mild synovitis by injection of 0.05 g calcium pyrophosphate crystals into canine kneeijoints (26) and found an increased albumin clearance but no changed half-life of albumin, whereas in acute synovitis induced by injection of 0.5 g or 500 g of calcium pyrophosphate a marked decrease of half-life was observed. Since Myers et al. presented only clearance values of their experiments, we calculated the corresponding half-lives from data given in their publication. PageThomas et al. determined the half-life of 131 I-labelled proteoglycan subunit in rabbit knee joints with and without experimental arthritis (27) . They found a half-life of 12.94 ± 0.63 hours for normal joints and a not significantly altered half-life in the presence of an active synovitis (14.49 ± 2.58 hours). Fräser et al. reported a gross reduction in the half-life of hyaluronan in synovial fluid in acute monoarticular arthritis induced by intra-articular injection of type II collagen into sheep hock joints (22) . The half-life fell from 20.8 ± 1.8 hours to 11.5 ± 1.1 hours (mean ± SEM) with a corresponding increase in mean fractional hyaluronan turnover from 3.5%/hour to 6.3%/hour. We suppose that the half-life of high molecular compounds in the joint seems not to be altered under conditions of a low grade synovitis, as seen in the rabbit model of osteoarthritis or in the model of Myers et al. (26) , whereas under inflammatory conditions the halflife is grossly reduced. At present we do not know the reason for the elevated half-life of hyaluronan in the osteoarthritis model of Colombo et al. when osteoarthritis is developing.
Our investigation was done with regard to an early diagnosis of osteoarthritis, which is urgently needed. Such investigations can be carried out on human beings only on a very limited scale, thus animal models have to be used. In contrast to human osteoarthritis, animal models of osteoarthritis allow the development of the disease in a relatively short time, enable pathophysiologic and pathobiochemical investigations of joint components and allow it to follow the process of the disease accurately. We chose the rabbit model of osteoarthritis because meniscectomy and ligament damage result in progressive degenerative changes of the joint which are similar to that in human osteoarthritis. It has to be proven whether the estimation of half-life of hyaluronan in the joint fluid will be of any value to the early diagnosis of human osteoarthritis.
It is difficult to discuss the hyaluronan concentrations of the synovial fluids in our groups (tab. 6) because hyaluronan concentration depends on different factors: Hyaluronan presumably accumulates in the joints during rest and is removed by physical exercise (7) . In the normal joint the main deposit seems to be in the lining layer while in the swollen inflamed synovium the hyaluronan is distributed throughout the perivascular spaces (7) . Therefore, we are not able to answer the question of why the hyaluronan concentration is decreased in osteoarthritis although hyaluronan synthesis is enhanced by osteoarthritic synovium and the half-life of hyaluronan is increased and unchanged, respectively. In the rabbit model of Colombo et al. the hyaluronan concentrations seem to be lowered at the stage of developing osteoarthritis but not at the stage of developed osteoarthritis.
